logo

For the Inventor, By the Inventor

IE

Janssen Alzheimer Immunotherapy


USPTO Granted Patents = 23



Forward Citations = 508

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Dale Bernard Schenk (9 out of 70 patents)

silverMedal Guriq Basi (5 out of 10 patents)

bronzeMedal Jose William Saldanha (3 out of 48 patents)

4.  Ranganathan Godavarti (3 out of 6 patents)

5.  Timothy Iskra (3 out of 4 patents)

6.  Theodore A Yednock (2 out of 25 patents)

7.  Ivan Lieberburg (2 out of 10 patents)

8.  James Callaway (2 out of 13 patents)

9.  Michael Grundman (2 out of 5 patents)

10.  Jack Steven Jacobsen (2 out of 11 patents)

11.  Angela Kantor (2 out of 5 patents)

12.  Nicki Vasquez (2 out of 3 patents)

13.  Donna L Luisi (2 out of 3 patents)

14.  Nicholas W Warne (2 out of 17 patents)

15.  Rasappa Gounder Arumugham (1 out of 12 patents)


23 patents:

1. 8916165 - Humanized Aβ antibodies for use in improving cognition (2014-12-23),
2. 8784810 - Treatment of amyloidogenic diseases (2014-07-22),
3. 8642044 - Prevention and treatment of amyloidogenic disease (2014-02-04),
4. 8613920 - Treatment of amyloidogenic diseases (2013-12-24),
5. 8535673 - Prevention and treatment of amyloidogenic disease (2013-09-17),
6. 8440799 - Methods of purifying anti A β antibodies (2013-05-14),
7. 8357781 - Neuroactive fragments of APP (2013-01-22),
8. 8318164 - Anti A beta antibody formulation (2012-11-27),
9. 8227403 - A-β immunogenic peptide carrier conjugates and methods of producing same (2012-07-24),
10. 8128928 - Humanized antibodies that recognize beta amyloid peptide (2012-03-06),
11. 8034348 - Prevention and treatment of amyloidogenic disease (2011-10-11),
12. 8034339 - Prevention and treatment of amyloidogenic disease (2011-10-11),
13. 8003097 - Treatment of cerebral amyloid angiopathy (2011-08-23),
14. 7964192 - Prevention and treatment of amyloidgenic disease (2011-06-21),
15. 7893214 - Humanized antibodies that recognize beta amyloid peptide (2011-02-22),
Janssen Alzheimer Immunotherapy, a subsidiary of Janssen Pharmaceuticals, is a biotechnology company focused on developing novel immunotherapies for Alzheimer's disease. Their mission is to discover innovative treatments that target and reduce the accumulation of amyloid-beta plaques in the brain, which is considered a hallmark pathology of Alzheimer's. Through their scientific expertise and dedication, Janssen Alzheimer Immunotherapy aims to revolutionize the future of Alzheimer's disease treatment and improve the lives of patients and their families.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

23 Patents

#6 in

#103 in Ireland

#26,820 in the World

...
IE

Janssen Alzheimer Immunotherapy

Forward Citations = 508

25 inventors:

goldMedal Dale Bernard Schenk (9 out of 70 patents)

silverMedal Guriq Basi (5 out of 10 patents)

bronzeMedal Jose William Saldanha (3 out of 48 patents)

4.  Ranganathan Godavarti (3 out of 6 patents)

5.  Timothy Iskra (3 out of 4 patents)

Please report any incorrect information to support@idiyas.com
Loading…